Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Bjorklund was prescribed Novos GLP-1 agonist drug, Ozempic for over a year after which she started Eli Lillys GLP-1/GIP co-agonist drug Mounjaro
Until now, patients taking the new class of GLP-1 drugs have had to choose from either a weekly injection that's stored in the refrigerator, like Ozempic, Wegovy, or Zepbound, or swallow a once-daily pill that requires patients to take it first thing in the morning on an empty stomach with a small glass of water (Rybelsus or Wegovy pill, from Novo Nordisk)
Nutrafol Hair Growth Nutraceuticals underwent our comprehensive Safety, Environmental & Regulatory Science (SERS) review, which includes a toxicological assessment of each ingredient and an evaluation of potential interactions with GLP-1 medications
Several other next-generation medications are also in development, each approaching weight management from different angles: Retatrutide is a new medication from Eli Lilly in trials that targets three hormones that control appetite and metabolism
No strong data favors either in humans
